Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125870361 | 12587036 | 1 | I | 20160715 | 20160725 | 20160725 | EXP | US-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00320 | SCIEGEN | 60.00 | YR | M | Y | 0.00000 | 20160725 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125870361 | 12587036 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 80 MG, QHS (FOR YEARS) | Y | U | 205519 | 80 | MG | TABLET | |||||
| 125870361 | 12587036 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 1000 MG DAILY | U | U | 0 | 1000 | MG | ||||||
| 125870361 | 12587036 | 3 | SS | ASA | ASPIRIN | 1 | Unknown | 81 MG DAILY | U | U | 0 | 81 | MG | ||||||
| 125870361 | 12587036 | 4 | SS | IBUPROFEN. | IBUPROFEN | 1 | Unknown | 800 MG TID PRN | U | U | 0 | 800 | MG | ||||||
| 125870361 | 12587036 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 800 MG, TID | U | U | 0 | 800 | MG | ||||||
| 125870361 | 12587036 | 6 | SS | Glyburide/Metformin | GLYBURIDEMETFORMIN | 1 | Unknown | 5/500 2 TABLETS BID | U | U | 0 | ||||||||
| 125870361 | 12587036 | 7 | SS | Lisinopril/HCTZ | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Unknown | 20/25 2 TABLETS DAILY | U | U | 0 | ||||||||
| 125870361 | 12587036 | 8 | SS | Ledipasvir/Sofosbuvir | LEDIPASVIRSOFOSBUVIR | 1 | Unknown | 1 TABLET DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125870361 | 12587036 | 1 | Product used for unknown indication |
| 125870361 | 12587036 | 2 | Product used for unknown indication |
| 125870361 | 12587036 | 3 | Product used for unknown indication |
| 125870361 | 12587036 | 4 | Product used for unknown indication |
| 125870361 | 12587036 | 5 | Product used for unknown indication |
| 125870361 | 12587036 | 6 | Product used for unknown indication |
| 125870361 | 12587036 | 7 | Product used for unknown indication |
| 125870361 | 12587036 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125870361 | 12587036 | LT |
| 125870361 | 12587036 | OT |
| 125870361 | 12587036 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125870361 | 12587036 | Acute kidney injury | |
| 125870361 | 12587036 | Chromaturia | |
| 125870361 | 12587036 | Leukocytosis | |
| 125870361 | 12587036 | Malaise | |
| 125870361 | 12587036 | Muscular weakness | |
| 125870361 | 12587036 | Myalgia | |
| 125870361 | 12587036 | Rhabdomyolysis | |
| 125870361 | 12587036 | Urine output decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |